BioPC Pro 30 SVG by Ortho Molecular Products

BioPC Pro 30 SVG

Ortho Molecular Products

$56.20
(No reviews yet) Write a Review
SKU:
OM-173030
Availability:
Ships Same Business Day
Maximum Purchase:
3 units
Already Registered?
How to Gain Access to Our Store?

BioPC Pro 30 SVG by Ortho Molecular Products

Phospholipids, or phosphatides, are an integral part of biological membranes, and they tend to decrease as we age. They are critical for cell and mitochondrial membrane shape, repair and growth. Proper cell membrane function facilitates healthy cell signaling, which is important for energy production, immune function and regulating inflammatory cascades. Additionally, BioPC Pro® leverages the benefits of a full-spectrum phosphatide blend to help process fats, balance the nervous system and bolster parasympathetic tone in patients who may be sympathetic dominant. BioPC Pro® also supports better focus, cognitive function and overall brain health. This high-concentration phosphatide blend is naturally bioavailable and rapidly absorbed.

BioPC Pro 30 SVG by Ortho Molecular Products—Effects

BioPC Pro 30 SVG may support:

  • your cellular health*
  • your mitochondrial health*
  • your immune response*
  • your brain function*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about BioPC Pro 30 SVG.

Recommendation:
Ortho Molecular Products suggests taking 1 scoop (10 grams) per day with a meal or as recommended by your health care professional. May be mixed in juice or shakes, or sprinkled on food.

Serving Size: 1 Scoop (10 grams)
Servings Per Container: About 30

Amount Per Serving:
Calories 60
Total Fat 5 g
Saturated Fat 1 g
Polyunsaturated Fat 3 g
Monounsaturated Fat 1 g
Total Carbohydrate 3 g
Protein <1 g
Sunflower Lecithin Powder 10 g
Phosphorus 130 mg

Other Ingredients: Mixed Tocopherols.

Typical naturally occuring phospholipid profile (per 10 g serving)‡:
Phosphatidylcholine 2.5 g (2,500 mg)
Phosphatidylinositol 2 g (2,000 mg)
Phosphatidylethanolamine 1 g (1,000 mg)
Phosphatidic acid 0.4 g (400 mg)
‡ subject to natural variability

Does Not Contain: Gluten, corn, yeast, artificial colors and flavors.

Cautions:
If you are pregnant or nursing, consult your physician before taking this product.

Click here to view Product Info Sheet

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

References:

  1. Nicolson, G. L., & Ash, M. E. (2014). Lipid replacement therapy: A natural medicine approach to replacing damaged lipids in cellular membranes and organelles and restoring function. Biochimica et Biophysica Acta, 1838(6), 1657–1679. https://doi.org/10.1016/j.bbamem.2013.11.010
  2. Furse, S., & de Kroon, A. I. (2015). Phosphatidylcholine’s functions beyond that of a membrane brick. Molecular Membrane Biology, 32(4), 117–119. https://doi.org/10.3109/09687688.2015.1066894
  3. Acoba, M. G., Senoo, N., & Claypool, S. M. (2020). Phospholipid ebb and flow makes mitochondria go. The Journal of Cell Biology, 219(8), e202003131. https://doi.org/10.1083/jcb.202003131
  4. Blaton, V., Vandamme, D., & Peeters, H. (1974). Activation of lipoprotein lipase in vitro by unsaturated phospholipids. FEBS Letters, 44(2), 185–188.
  5. Horsch, A. K., Hudson, K., & Day, A. J. (1977). Uptake and metabolism of 3H-fatty acid labelled lecithin by normal and atherosclerotic intima in vivo and in vitro. Atherosclerosis, 26(4), 493–504.
  6. Howard, A. N., & Patelski, J. (1974). Hydrolysis and synthesis of aortic cholesterol esters in atherosclerotic baboons: Effect of polyunsaturated phosphatidylcholine on enzyme activities. Atherosclerosis, 20(2), 225–232.
  7. Waligora, Z., Patelski, J., Brown, B. D., & Howard, A. N. (1975). Effect of a hypercholesterolaemic diet and a single injection of polyunsaturated phosphatidylcholine solution on the activities of lipolytic enzymes, acyl-CoA synthetase and acyl-CoA cholesterol acyl-transferase in rabbit tissues. Biochemical Pharmacology, 24(24), 2263–2267.
  8. Karaman, A., Demirbilek, S., Sezgin, N., Gürbüz, N., & Gürses, I. (2003). Protective effect of polyunsaturated phosphatidylcholine on liver damage induced by biliary obstruction in rats. Journal of Pediatric Surgery, 38(9), 1341–1347.
  9. Olbrich, K., Rawicz, W., Needham, D., & Evans, E. (2000). Water permeability and mechanical strength of polyunsaturated lipid bilayers. Biophysical Journal, 79(1), 321–327.
  10. Buko, V., Artsukevich, A., Maltsev, A., Nikitin, V., Ignatenko, K., Gundermann, K. J., & Schumacher, R. (1994). Effect of polyunsaturated phosphatidylcholine on lipid structure and cAMP-dependent signal transduction in the liver of rats chronically intoxicated with ethanol. Experimental and Toxicologic Pathology, 46(4–5), 375–382.
  11. Nicolson, G. (2003). Lipid replacement as an adjunct to therapy for chronic fatigue, anti-aging and restoration of mitochondrial function. The Journal of the American Nutraceutical Association, 6(3), 4–10.
  12. Nicolson, G. L., & Ellithorpe, R. (2006). Lipid replacement and antioxidant nutritional therapy for restoring mitochondrial function and reducing fatigue in chronic fatigue syndrome and other fatiguing illnesses. Journal of Chronic Fatigue Syndrome, 13(1), 57–68.
  13. Nicolson, G. L. (2005). Lipid replacement/antioxidant therapy as an adjunct supplement to reduce the adverse effects of cancer therapy and restore mitochondrial function. Pathology & Oncology Research, 11(3), 139–144.
  14. Zierenberg, O., & Grundy, S. M. (1982). Intestinal absorption of polyenephosphatidylcholine in man. Journal of Lipid Research, 23(8), 1136–1142.